Production (Stage)
Xilio Therapeutics, Inc.
XLO
$0.8838
-$0.0132-1.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 162.13% | 23.68% | 2.49% | -0.58% | -63.57% |
| Total Receivables | -93.33% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -59.14% | -14.02% | -56.46% | 0.56% | 40.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.71% | 25.16% | -1.82% | -0.53% | -28.66% |
|
|
|||||
| Total Current Assets | 34.71% | 25.16% | -1.82% | -0.53% | -28.66% |
| Net Property, Plant & Equipment | -17.19% | -19.12% | -17.56% | -17.75% | -17.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.00% | 11.51% | 1.49% | 5.08% | 60.22% |
| Total Assets | 25.55% | 16.66% | -4.09% | -2.69% | -25.91% |
|
|
|||||
| Total Accounts Payable | 204.96% | 145.14% | -34.59% | 33.76% | -62.94% |
| Total Accrued Expenses | -51.47% | -4.92% | 4.14% | 36.37% | 23.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.55% | -73.06% | -80.92% | -86.32% | -85.59% |
| Total Finance Division Other Current Liabilities | 85.28% | -- | -- | -- | -- |
| Total Other Current Liabilities | 85.28% | -- | -- | -- | -- |
| Total Current Liabilities | 50.84% | 70.84% | 124.60% | 137.16% | 95.02% |
|
|
|||||
| Total Current Liabilities | 50.84% | 70.84% | 124.60% | 137.16% | 95.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.58% | -14.59% | -13.69% | -12.92% | -12.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 122.66% | -- | -- | -- | -- |
| Total Liabilities | 63.63% | 121.91% | 111.82% | 125.99% | 112.80% |
|
|
|||||
| Common Stock & APIC | 10.65% | 10.77% | 8.68% | 8.81% | 3.35% |
| Retained Earnings | -15.84% | -17.89% | -20.40% | -22.51% | -26.11% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -58.47% | -52.21% | -60.05% | -50.40% | -69.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -58.47% | -52.21% | -60.05% | -50.40% | -69.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -58.47% | -52.21% | -60.05% | -50.40% | -69.61% |
|
|
|||||